Zimmer Biomet Holdings Inc. [ZBH] stock Initiated by Wolfe Research analyst, price target now $174

Zimmer Biomet Holdings Inc. [NYSE: ZBH] traded at a high on 09/30/20, posting a 2.05 gain after which it closed the day’ session at $136.14.

The results of the trading session contributed to over 1008582 shares changing hands. Over the past one week, the price volatility of Zimmer Biomet Holdings Inc. stands at 3.14% while the volatility over the past one month is 2.65%.

The market cap for ZBH stock reached $27.58 billion, with 206.80 million shares outstanding and 206.65 million shares in the current float. Compared to the average trading volume of 1.10M shares, ZBH reached a trading volume of 1008582 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Zimmer Biomet Holdings Inc. [ZBH]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZBH shares is $149.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZBH stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wolfe Research have made an estimate for Zimmer Biomet Holdings Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on September 11, 2020. While these analysts kept the previous recommendation, Needham raised their target price from $148 to $162. The new note on the price target was released on August 05, 2020, representing the official price target for Zimmer Biomet Holdings Inc. stock.

The Average True Range (ATR) for Zimmer Biomet Holdings Inc. is set at 3.80, with the Price to Sales ratio for ZBH stock in the period of the last 12 months amounting to 3.92. The Price to Book ratio for the last quarter was 2.42, with the Price to Cash per share for the same quarter was set at 3.52. Price to Free Cash Flow for ZBH in the course of the last twelve months was 26.72 with Quick ratio for the last quarter at 1.00.

How has ZBH stock performed recently?

Zimmer Biomet Holdings Inc. [ZBH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.79. With this latest performance, ZBH shares dropped by -3.36% in over the last four-week period, additionally plugging by 51.89% over the last 6 months – not to mention a rise of 1.89% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZBH stock in for the last two-week period is set at 47.81, with the RSI for the last a single of trading hit 47.81, and the three-weeks RSI is set at 49.38 for Zimmer Biomet Holdings Inc. [ZBH]. The present Moving Average for the last 50 days of trading for this stock 137.49, while it was recorded at 134.60 for the last single week of trading, and 130.54 for the last 200 days.

Zimmer Biomet Holdings Inc. [ZBH]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Zimmer Biomet Holdings Inc. [ZBH] shares currently have an operating margin of +15.13 and a Gross Margin at +63.98. Zimmer Biomet Holdings Inc.’s Net Margin is presently recorded at +14.18.

Return on Total Capital for ZBH is now 5.88, given the latest momentum, and Return on Invested Capital for the company is 5.80. Return on Equity for this stock inclined to 9.57, with Return on Assets sitting at 4.64. When it comes to the capital structure of this company, Zimmer Biomet Holdings Inc. [ZBH] has a Total Debt to Total Equity ratio set at 68.62. Additionally, ZBH Total Debt to Total Capital is recorded at 40.70, with Total Debt to Total Assets ending up at 34.50. Long-Term Debt to Equity for the company is recorded at 56.00, with the Long-Term Debt to Total Capital now at 33.21.

Reflecting on the efficiency of the workforce at the company, Zimmer Biomet Holdings Inc. [ZBH] managed to generate an average of $56,864 per employee. Receivables Turnover for the company is 6.05 with a Total Asset Turnover recorded at a value of 0.33.Zimmer Biomet Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 2.20.

Earnings analysis for Zimmer Biomet Holdings Inc. [ZBH]

With the latest financial reports released by the company, Zimmer Biomet Holdings Inc. posted 1.77/share EPS, while the average EPS was predicted by analysts to be reported at 1.75/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZBH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zimmer Biomet Holdings Inc. go to 3.66%.

Insider trade positions for Zimmer Biomet Holdings Inc. [ZBH]

There are presently around $25,267 million, or 90.50% of ZBH stock, in the hands of institutional investors. The top three institutional holders of ZBH stocks are: VANGUARD GROUP INC with ownership of 16,093,482, which is approximately -1.22% of the company’s market cap and around 0.17% of the total institutional ownership; BLACKROCK INC., holding 14,477,051 shares of the stock with an approximate value of $1.97 billion in ZBH stocks shares; and MASSACHUSETTS FINANCIAL SERVICES CO /MA/, currently with $1.4 billion in ZBH stock with ownership of nearly -3.301% of the company’s market capitalization.

Positions in Zimmer Biomet Holdings Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 402 institutional holders increased their position in Zimmer Biomet Holdings Inc. [NYSE:ZBH] by around 19,834,711 shares. Additionally, 426 investors decreased positions by around 18,243,881 shares, while 184 investors held positions by with 147,518,450 shares. The mentioned changes placed institutional holdings at 185,597,042 shares, according to the latest SEC report filing. ZBH stock had 128 new institutional investments in for a total of 6,031,768 shares, while 66 institutional investors sold positions of 1,705,922 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam